-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVABRIDGE DOSES FIRST PATIENT IN GLOBAL, RANDOMIZED PHASE 2 STUDY OF GIVASTOMIG COMBINED WITH IMMUNOCHEMOTHERAPY IN PATIENTS WITH 1L METASTATIC GASTRIC CANCER

Reuters·02/17/2026 21:05:02

Please log in to view news